Atlas Trials

Clinical Effect of Caffeine Consumption in Patients Taking Oral Terbinafine

Clinical trial NCT05667246 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT05667246
Sponsor
Weill Medical College of Cornell University
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
Terbinafine Adverse Reaction
Start date
2024-07-25
Primary completion
2026-12-31
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.